Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.10
+0.07 (0.78%)
Mar 31, 2025, 2:33 PM EDT - Market open
Bioventus Market Cap
Bioventus has a market cap or net worth of $602.03 million as of March 31, 2025. Its market cap has increased by 79.56% in one year.
Market Cap
602.03M
Enterprise Value
911.87M
1-Year Change
79.56%
Ranking
Category
Stock Price
$9.10
Market Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has decreased from $713.47M to $602.03M, a decrease of -15.62%. That is a compound annual growth rate of -4.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 597.40M | -12.96% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |